Common side effects of Sparsentan include hyperkalemia, hypotension, peripheral edema, dizziness, anemia, and acute kidney injury.
The most common side effects observed in clinical trials include hyperkalemia (17%), hypotension (16%), peripheral edema (16%), dizziness (16%), and anemia (8%). Severe side effects can include liver toxicity, acute kidney injury, and fluid retention. Regular monitoring for these side effects is essential.

